JP2021534162A5 - - Google Patents
Info
- Publication number
- JP2021534162A5 JP2021534162A5 JP2021507760A JP2021507760A JP2021534162A5 JP 2021534162 A5 JP2021534162 A5 JP 2021534162A5 JP 2021507760 A JP2021507760 A JP 2021507760A JP 2021507760 A JP2021507760 A JP 2021507760A JP 2021534162 A5 JP2021534162 A5 JP 2021534162A5
- Authority
- JP
- Japan
- Prior art keywords
- agent according
- pharmaceutical composition
- formula
- peg
- agent
- Prior art date
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862719314P | 2018-08-17 | 2018-08-17 | |
| US62/719,314 | 2018-08-17 | ||
| PCT/IB2019/056926 WO2020035816A1 (en) | 2018-08-17 | 2019-08-15 | Conjugates for use in methods of treating cancer |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| JP2021534162A JP2021534162A (ja) | 2021-12-09 |
| JP2021534162A5 true JP2021534162A5 (https=) | 2022-08-22 |
| JPWO2020035816A5 JPWO2020035816A5 (https=) | 2022-08-22 |
| JP7506659B2 JP7506659B2 (ja) | 2024-06-26 |
Family
ID=68104689
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021507760A Active JP7506659B2 (ja) | 2018-08-17 | 2019-08-15 | 癌を処置する方法に用いられるコンジュゲート |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US20220273807A1 (https=) |
| EP (1) | EP3836973A1 (https=) |
| JP (1) | JP7506659B2 (https=) |
| KR (1) | KR20210047301A (https=) |
| CN (1) | CN112584869A (https=) |
| AU (1) | AU2019321091C1 (https=) |
| BR (1) | BR112021002147A2 (https=) |
| CA (1) | CA3108638A1 (https=) |
| EA (1) | EA202190457A1 (https=) |
| IL (1) | IL280830A (https=) |
| MX (1) | MX2021001832A (https=) |
| SG (1) | SG11202101395XA (https=) |
| TW (1) | TWI831817B (https=) |
| WO (1) | WO2020035816A1 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI773730B (zh) * | 2017-02-22 | 2022-08-11 | 瑞典商阿斯特捷利康公司 | 治療性樹枝狀聚合物 |
| TWI856967B (zh) * | 2018-08-17 | 2024-10-01 | 瑞典商阿斯特捷利康公司 | 樹枝狀體配製物 |
| US20230250077A1 (en) * | 2020-07-10 | 2023-08-10 | Jiangsu Hengrui Pharmaceuticals Co., Ltd. | Sulfonylbenzamide derivative and conjugate thereof, preparation method therefor and use thereof |
| US20230263900A1 (en) * | 2020-08-31 | 2023-08-24 | Starpharma Pty Ltd. | Dendrimer-drug conjugate |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI535712B (zh) * | 2010-08-06 | 2016-06-01 | 阿斯特捷利康公司 | 化合物 |
| BR112013031556B1 (pt) * | 2011-06-06 | 2022-03-29 | Starpharma Pty Ltd | Macromoléculas, uso das mesmas para tratar ou suprimir o crescimento de um câncer e composições farmacêuticas |
| WO2015035446A1 (en) * | 2013-09-10 | 2015-03-19 | Starpharma Pty Ltd | Macromolecules of dendrimer-platinum conjugates |
| TWI773730B (zh) * | 2017-02-22 | 2022-08-11 | 瑞典商阿斯特捷利康公司 | 治療性樹枝狀聚合物 |
-
2019
- 2019-08-08 TW TW108128356A patent/TWI831817B/zh not_active IP Right Cessation
- 2019-08-15 EA EA202190457A patent/EA202190457A1/ru unknown
- 2019-08-15 CN CN201980053352.4A patent/CN112584869A/zh active Pending
- 2019-08-15 SG SG11202101395XA patent/SG11202101395XA/en unknown
- 2019-08-15 CA CA3108638A patent/CA3108638A1/en active Pending
- 2019-08-15 AU AU2019321091A patent/AU2019321091C1/en not_active Ceased
- 2019-08-15 MX MX2021001832A patent/MX2021001832A/es unknown
- 2019-08-15 BR BR112021002147-7A patent/BR112021002147A2/pt not_active Application Discontinuation
- 2019-08-15 WO PCT/IB2019/056926 patent/WO2020035816A1/en not_active Ceased
- 2019-08-15 EP EP19779977.8A patent/EP3836973A1/en active Pending
- 2019-08-15 JP JP2021507760A patent/JP7506659B2/ja active Active
- 2019-08-15 KR KR1020217004509A patent/KR20210047301A/ko not_active Ceased
- 2019-08-15 US US17/268,633 patent/US20220273807A1/en not_active Abandoned
-
2021
- 2021-02-11 IL IL280830A patent/IL280830A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021534162A5 (https=) | ||
| US8466127B2 (en) | Pegylated and fatty acid grafted chitosan oligosaccharide, synthesis method and application for drug delivery system | |
| CN101808651B (zh) | 类固醇类的高分子结合物 | |
| TWI394774B (zh) | Novel block copolymers, microcell modifiers, and anticancer agents that are useful as an active ingredient | |
| US10428114B2 (en) | Type polypeptide targeting tumours | |
| EP2242514B1 (en) | Intralymphatic chemotherapy drug carriers | |
| KR102811484B1 (ko) | 치료 덴드리머 | |
| KR20150020180A (ko) | 안티센스 올리고뉴클레오티드 전달을 위한 지질 나노입자 조성물 | |
| WO2011058776A1 (ja) | ブロックコポリマー、ブロックコポリマー－金属錯体複合体、及びそれを用いた中空構造体キャリア | |
| EP2359860B1 (en) | Polymer micelle composition for treatment of resistant cancer cells | |
| US9539273B2 (en) | Targeted delivery of anti-fungal agents | |
| Elbialy et al. | Bioinspired synthesis of protein/polysaccharide-decorated folate as a nanocarrier of curcumin to potentiate cancer therapy | |
| CN111793147A (zh) | 改性壳聚糖、双响应纳米载体药及其制备方法和应用 | |
| Liu et al. | A dynamic covalent bonding-based nanoplatform for intracellular co-delivery of protein drugs and chemotherapeutics with enhanced anti-cancer effect | |
| KR20240083166A (ko) | 폐를 표적장기로 하는 생분해성 지질나노입자 약물 전달 제형 및 이의 활용 | |
| JPWO2020035816A5 (https=) | ||
| US12071517B2 (en) | Therapeutic dendrimer | |
| KR20220022829A (ko) | 글리시리진 및 수용성 약물을 포함하는 나노 입자, 이를 포함하는 약제학적 조성물 및 이들의 제조 방법 | |
| WO2025067389A1 (en) | Lipid complex nanoparticle for lung-targeted delivery of nucleic acid therapeutic agent | |
| KR102745759B1 (ko) | Pd-l1 표적화 나노입자, 이를 포함하는 암 예방 또는 치료용 약학 조성물 및 이들의 제조방법 | |
| WO2026021576A1 (zh) | 一种核酸脂质纳米载体及其制备方法与应用 | |
| CN101278913A (zh) | 一种新型的peg衍生化磷脂包载前列腺素e1的胶束制剂 | |
| Guo | Cationic Amino Acid-Modified Camptothecin Prodrugs with Typical Helix Self-Assembly for Combination Cancer Therapy | |
| US20250360158A1 (en) | Oligonucleotide analogue formulations | |
| WO2020158863A1 (ja) | アントラサイクリン系化合物を含むミセル剤と免疫賦活剤との組み合わせ医薬 |